Clinical trial
Topical Ophthalmic AGN-195263 for the Treatment of Evaporative Dry Eye
NCT02815293 is registered in ClinicalTrials.gov with Allergan as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Topical Ophthalmic AGN-195263 for the Treatment of Evaporative Dry Eye
- Lead sponsor
- Allergan
- Phase
- Phase 3
- Overall status
- Terminated
- Start date
- September 30, 2016
- Completion date
- June 21, 2017
- Enrollment
- 36 (actual)
- Sites
- 29
Conditions
As the registry lists them; a condition with its own page is linked.